Sign In

Login

Password

Forgot Password ? Sign Up

Ginkgo biloba (Portuguese Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ginkgo biloba" in Portuguese language version.

refsWebsite
Global rank Portuguese rank
9doi.org
2nd place
4th place
8nih.gov
4th place
8th place
1iucnredlist.org
88th place
81st place
1kew.org
394th place
901st place
1nytimes.com
7th place
14th place
1bbc.co.uk
8th place
13th place
1who.int
195th place
150th place

bbc.co.uk

news.bbc.co.uk

doi.org

dx.doi.org

  • Mustoe, G.E. (2002). «Eocene Ginkgo leaf fossils from the Pacific Northwest». Canadian Journal of Botany. 80 (10): 1078–1087. doi:10.1139/b02-097 
  • Sun, W. (1998). «Ginkgo biloba». Lista Vermelha de Espécies Ameaçadas. 1998: e.T32353A9700472. doi:10.2305/IUCN.UK.1998.RLTS.T32353A9700472.enAcessível livremente. Consultado em 19 de novembro de 2021 
  • Mahadevan, S.; Park, Y. (2007). «Multifaceted Therapeutic Benefits of Ginkgo biloba L.: Chemistry, Efficacy, Safety, and Uses». Journal of Food Science. 73 (1): R14–9. PMID 18211362. doi:10.1111/j.1750-3841.2007.00597.x 
  • DeKosky, Steven T.; Williamson, Jeff D.; Fitzpatrick, Annette L.; Kronmal, R. A.; Ives, D. G.; Saxton, J. A.; Lopez, O. L.; Burke, G.; Carlson, M. C. (2008). «Ginkgo biloba for Prevention of Dementia». The Journal of the American Medical Association. 300 (19): 2253–2262. PMID 19017911. doi:10.1001/jama.2008.683 
  • Ihl R, Bachinskaya N, Korczyn AD, Vakhapova V, Tribanek M, Hoerr R, Napryeyenko O (2010). «Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial». Int J Geriatr Psychiatry: n/a. PMID 21140383. doi:10.1002/gps.2662 
  • Elsabagh, Sarah; Hartley, David E.; Ali, Osama; Williamson, Elizabeth M.; File, Sandra E. (2005). «Differential cognitive effects of Ginkgo biloba after acute and chronic treatment in healthy young volunteers». Psychopharmacology. 179 (2): 437–46. PMID 15739076. doi:10.1007/s00213-005-2206-6 
  • Kennedy, David O.; Scholey, Andrew B.; Wesnes, Keith A. (2000). «The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers». Psychopharmacology. 151 (4): 416–23. PMID 11026748. doi:10.1007/s002130000501 
  • Fehske, Christian J.; Leuner, Kristina; Müller, Walter E. (2009). «Ginkgo biloba extract (EGb761®) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment». Pharmacological Research. 60 (1): 68–73. PMID 19427589. doi:10.1016/j.phrs.2009.02.012 
  • «[Ginkgo biloba - effect, adverse events and drug interaction]». Norwegian Medical Association. 2012. PMID 22562327. doi:10.4045/tidsskr.11.0780 

iucnredlist.org

kew.org

powo.science.kew.org

nih.gov

ncbi.nlm.nih.gov

  • Mahadevan, S.; Park, Y. (2007). «Multifaceted Therapeutic Benefits of Ginkgo biloba L.: Chemistry, Efficacy, Safety, and Uses». Journal of Food Science. 73 (1): R14–9. PMID 18211362. doi:10.1111/j.1750-3841.2007.00597.x 
  • DeKosky, Steven T.; Williamson, Jeff D.; Fitzpatrick, Annette L.; Kronmal, R. A.; Ives, D. G.; Saxton, J. A.; Lopez, O. L.; Burke, G.; Carlson, M. C. (2008). «Ginkgo biloba for Prevention of Dementia». The Journal of the American Medical Association. 300 (19): 2253–2262. PMID 19017911. doi:10.1001/jama.2008.683 
  • Ihl R, Bachinskaya N, Korczyn AD, Vakhapova V, Tribanek M, Hoerr R, Napryeyenko O (2010). «Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial». Int J Geriatr Psychiatry: n/a. PMID 21140383. doi:10.1002/gps.2662 
  • Elsabagh, Sarah; Hartley, David E.; Ali, Osama; Williamson, Elizabeth M.; File, Sandra E. (2005). «Differential cognitive effects of Ginkgo biloba after acute and chronic treatment in healthy young volunteers». Psychopharmacology. 179 (2): 437–46. PMID 15739076. doi:10.1007/s00213-005-2206-6 
  • Kennedy, David O.; Scholey, Andrew B.; Wesnes, Keith A. (2000). «The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers». Psychopharmacology. 151 (4): 416–23. PMID 11026748. doi:10.1007/s002130000501 
  • «Ginkgo biloba is not a smart drug: an updated systematic review of randomised clinical trials testing the nootropic effects of G. biloba extracts in healthy people». Human Psychopharmacology: Clinical and Experimental. 22 (5): 265–278. 2007. PMID 17480002 
  • Fehske, Christian J.; Leuner, Kristina; Müller, Walter E. (2009). «Ginkgo biloba extract (EGb761®) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment». Pharmacological Research. 60 (1): 68–73. PMID 19427589. doi:10.1016/j.phrs.2009.02.012 
  • «[Ginkgo biloba - effect, adverse events and drug interaction]». Norwegian Medical Association. 2012. PMID 22562327. doi:10.4045/tidsskr.11.0780 

nytimes.com

who.int

monographs.iarc.who.int